O
31
3
AME
57
-2
CNX
80
4
VLO
40
-5
LEG
27
-2
AEE
61
3
WBA
24
-3
MS
64
7
BF.B
43
-7
FTI
82
4
LNC
52
2
DUK
64
2
IBM
81
3
XRAY
31
-3
VZ
47
2
SWK
81
-3
AVB
65
-2
STI
17
3
CVS
45
-4
ILMN
41
-3
O
31
3
AME
57
-2
CNX
80
4
VLO
40
-5
LEG
27
-2
AEE
61
3
WBA
24
-3
MS
64
7
BF.B
43
-7
FTI
82
4
LNC
52
2
DUK
64
2
IBM
81
3
XRAY
31
-3
VZ
47
2
SWK
81
-3
AVB
65
-2
STI
17
3
CVS
45
-4
ILMN
41
-3
Financhill
Back

Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
39

DRIP
Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF

Last Price:
11.14
Seasonality Move:
5.44%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
39
Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF (DRIP) is a Sell

Is Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF a Buy, Sell or Hold?

  • The current Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF [DRIP] share price is $11.14. The Score for DRIP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • DRIP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DRIP Stock Price Chart

What is Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF's stock price today?

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

DRIP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.25 Buy
Relative Strength Index (14 RSI): 47.25 Sell
Chaikin Money Flow: -1344097 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.49 - 12.03) Sell
Bollinger Bands (100): (9.15 - 11.05) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

DRIP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.81 Sell
20-day SMA: 11.42 Sell
50-day SMA: 10.72 Buy
200-day SMA: 10.37 Buy
8-day EMA: 11.55 Sell
20-day EMA: 11.45 Sell
50-day EMA: 10.91 Buy
200-day EMA: 10.85 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF Earnings Growth & DRIP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Direxion Dly S&P Oil&Gs Ex&Prd Br 2X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):